Thermo Fisher nixes $12.7B Qiagen acquisition after shareholders opt out

The Waltham life sciences giant failed to convince enough shareholders of the Dutch testing firm to sell despite hiking its offer by nearly 14% last month.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 13, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news